Moody’s affirms Temple University Health System’s ‘Ba1’ rating

Moody’s Investors Service affirmed Philadelphia-based Temple University Health System’s “Ba1” bond rating, affecting $478 million of debt.

Advertisement

The rating reflects Moody’s belief that the hospital’s execution risks will be elevated as management looks for ways to reduce deficits and grow liquidity.

The rating outlook has been revised from stable to negative.

More articles on healthcare finance:

Private equity pushes into healthcare: 8 latest deals
Moody’s: How CHS, Tenet and LifePoint are offsetting industry challenges
Amazon, Apple join growing list of companies opening on-site clinics for employees

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.